Related Experiment Video
Updated: Jun 17, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Platelet von Willebrand factor--structure, function and biological importance
Rachel T McGrath1, Emily McRae, Owen P Smith
1Haemostasis Research Group, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital, Trinity College, Dublin 8, Ireland.
Platelet von Willebrand factor (VWF) differs from plasma VWF in glycosylation and function, impacting primary hemostasis and von Willebrand disease (VWD) patient variability.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Background:
- Von Willebrand factor (VWF) circulates in plasma and is stored in platelet alpha-granules.
- Platelet VWF is distinct from plasma VWF, enriched in high molecular weight multimers, and possesses a unique glycosylation profile.
Purpose of the Study:
- To investigate the distinct biochemical and functional properties of platelet VWF compared to plasma VWF.
- To understand the implications of these differences in primary hemostasis and von Willebrand disease (VWD).
Main Methods:
- Comparative analysis of VWF glycosylation (sialic acid, galactose, ABO determinants) between plasma and platelet pools.
- Assessment of functional properties and haemostatic activity of platelet and plasma VWF.
- Review of animal model studies and clinical observations in VWD patients.
Main Results:
- Platelet VWF shows reduced sialic acid and galactose expression and lacks ABO blood group determinants on its N-linked glycans compared to plasma VWF.
- These glycosylation differences lead to distinct functional properties of platelet VWF.
- Both plasma and platelet VWF are crucial for primary hemostasis, with varying levels observed in different VWD types.
Conclusions:
- The unique biochemical characteristics of platelet VWF contribute to its distinct functional role in hemostasis.
- Understanding the differences between plasma and platelet VWF is vital for basic science and has direct translational importance for VWD management.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

